Show simple item record

dc.contributor.authorSilecchia, Valeria
dc.contributor.authorValerio, Enrico
dc.contributor.authorFilippone, Marco
dc.contributor.authorBalao, Laura
dc.contributor.authorCherubin, Emanuele
dc.contributor.authorRigon, Luca
dc.contributor.authorGrimalt Santacana, Ramon
dc.contributor.authorCutrone, Mario
dc.date.accessioned2021-09-30T14:00:01Z
dc.date.available2021-09-30T14:00:01Z
dc.date.issued2019
dc.identifier.citationSilecchia, Valeria; Valerio, Enrico; Filippone, Marco [et al.]. Phakomatosis pigmentovascularis cesioflammea. Journal of Dermatological Research, 2019, 4(2), p. 187-188. Disponible en: <http://www.ghrnet.org/index.php/jdr/article/view/2735>. Fecha de acceso: 30 sep. 2021. DOI: 10.17554/j.issn.2413-8223.2019.04.46-9ca
dc.identifier.issn2413-8223ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/2830
dc.description.abstractnCPAP-induced nose skin injury is a common issue in NICUs all over the world. Damage may vary from simple hyperemia in the region of application of nasal cannulae up to complete destruction of the columellar region. We here report a case series of three patients displaying various grades of nasal damage, ranging from soft hyperemia to ulcerative lesions, up to complete columellar breakdown. Not only lesions with loss of substance are documented in literature; cases of post-discharge nasal vestibular stenosis and nasal synechiae obstruction are also reported. Risk factors for nCPAP-induced nasal injury include low birth weight, low gestational age, and increased time on nCPAP. Good clinical practices to prevent and treat nCPAP-induced skin damage are here briefly reviewed; strong efforts must be spent in NICU personnel education in order to enhance awareness about this topic and ensure a correct prevention.en
dc.format.extent2ca
dc.language.isoengca
dc.publisherACT Publishingca
dc.relation.ispartofJournal of Respiratory Researchca
dc.relation.ispartofseries4;2
dc.rightsThis article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/en
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherDermatologiaca
dc.subject.otherNeonatologiaca
dc.subject.otherSíndrome de Downca
dc.subject.otherTrisomia 21ca
dc.subject.otherDermatologíaes
dc.subject.otherNeonatologíaes
dc.subject.otherSíndrome de Downes
dc.subject.otherTrisomía 21es
dc.subject.otherDermatologyen
dc.subject.otherNeonatologyen
dc.subject.otherDown syndromeen
dc.subject.otherTrisomy 21en
dc.titlePhakomatosis pigmentovascularis cesioflammeaen
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.subject.udc616.5ca
dc.identifier.doihttps://dx.doi.org/10.17554/j.issn.2413-8223.2019.04.46-9ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/